Abstract
Background: Hypovitaminosis D and low testosterone levels are common in men with T2DM, and vitamin D has been proposed to regulate pituitary-testicular function.
Objective: We investigated the association between testosterone levels and the circulating vitamin D among type 2 diabetic males.
Methods: We recruited 95 males with type 2 diabetes in this cross-sectional study and investigated the circulating form of vitamin D, which is 25-hydroxyvitamin D (25(OH) D). 25(OH) D level <30 ng/mL was used to define vitamin D insufficiency, and 25(OH) D level <20 ng/ml was defined as a deficiency. Testosterone deficiency was described as a total testosterone level less than 300 ng/dl.
Result: Testosterone deficiency prevalence in type 2 diabetic males was found to be 46.3%. Testosterone deficient people with diabetes had significantly lower 25(OH) D levels than patients with normal testosterone. We observed a higher prevalence of vitamin D deficiency in testosterone deficient people with diabetes than testosterone sufficient patients. Furthermore, significantly lower total testosterone levels but not LH levels were observed in diabetic males with vitamin D deficiency compared to nondeficient patients. We observed that 25(OH) D significantly predicted total testosterone levels in diabetic males evaluated by linear regression analysis. However, this association was no longer statistically significant after excluding macro-albuminuric patients. Moreover, vitamin D deficiency was found to be a significant risk factor for testosterone deficiency in logistic regression analysis.
Conclusion: Testosterone deficient males with diabetes had significantly lower 25(OH)D levels and a higher prevalence of vitamin D deficiency than normal testosterone diabetic males. Likewise, vitamin D deficient patients had lower testosterone levels. Overall, 25(OH) D significantly predicted total testosterone levels. Vitamin D deficiency was thus a significant risk factor for testosterone deficiency in diabetic males.
Keywords: Vitamin D, testosterone, type 2 DM, male hypogonadism, 25OH D, testosterone deficiency.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:The Correlation between 25-Hydroxyvitamin D Levels and Testosterone Levels in Type 2 Diabetic Male Patients
Volume: 23
Author(s): Mohamed M. Aboelnaga*, Abdullah Nahed, Sherihan I. Gouda and Amro Elbaz
Affiliation:
- Department of Endocrinology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Keywords: Vitamin D, testosterone, type 2 DM, male hypogonadism, 25OH D, testosterone deficiency.
Abstract:
Background: Hypovitaminosis D and low testosterone levels are common in men with T2DM, and vitamin D has been proposed to regulate pituitary-testicular function.
Objective: We investigated the association between testosterone levels and the circulating vitamin D among type 2 diabetic males.
Methods: We recruited 95 males with type 2 diabetes in this cross-sectional study and investigated the circulating form of vitamin D, which is 25-hydroxyvitamin D (25(OH) D). 25(OH) D level <30 ng/mL was used to define vitamin D insufficiency, and 25(OH) D level <20 ng/ml was defined as a deficiency. Testosterone deficiency was described as a total testosterone level less than 300 ng/dl.
Result: Testosterone deficiency prevalence in type 2 diabetic males was found to be 46.3%. Testosterone deficient people with diabetes had significantly lower 25(OH) D levels than patients with normal testosterone. We observed a higher prevalence of vitamin D deficiency in testosterone deficient people with diabetes than testosterone sufficient patients. Furthermore, significantly lower total testosterone levels but not LH levels were observed in diabetic males with vitamin D deficiency compared to nondeficient patients. We observed that 25(OH) D significantly predicted total testosterone levels in diabetic males evaluated by linear regression analysis. However, this association was no longer statistically significant after excluding macro-albuminuric patients. Moreover, vitamin D deficiency was found to be a significant risk factor for testosterone deficiency in logistic regression analysis.
Conclusion: Testosterone deficient males with diabetes had significantly lower 25(OH)D levels and a higher prevalence of vitamin D deficiency than normal testosterone diabetic males. Likewise, vitamin D deficient patients had lower testosterone levels. Overall, 25(OH) D significantly predicted total testosterone levels. Vitamin D deficiency was thus a significant risk factor for testosterone deficiency in diabetic males.
Export Options
About this article
Cite this article as:
Aboelnaga M. Mohamed*, Nahed Abdullah, Gouda I. Sherihan and Elbaz Amro, The Correlation between 25-Hydroxyvitamin D Levels and Testosterone Levels in Type 2 Diabetic Male Patients, Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23 () . https://dx.doi.org/10.2174/1871530322666220524104929
DOI https://dx.doi.org/10.2174/1871530322666220524104929 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
Call for Papers in Thematic Issues
Association between Diabetes Mellitus and natural product complementary applications: State of the arts
Diabetes Mellitus (DM) represents a significant global health challenge, characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The increasing prevalence of DM, alongside its associated complications, has prompted researchers and healthcare professionals to explore a variety of management strategies beyond conventional pharmacotherapy. Among these ...read more
Chronic inflammation and Disorders/Cancers
Chronic inflammation is fundamental cause of variety of disorders. Many lifestyle-related diseases including metabolic syndrome, obesity, impairment of immune responses, sepsis, mental illness, and other disorders are caused by chronic inflammation. Prevention of chronic inflammation is related to antiaging effects of our body. Proinflammatory cytokines such as TNF-α is associated ...read more
Immune defense of the blood-tissue barriers which are related to drugs, metabolic and hormones
We have already known that testis is an immune privilege area for the maintenance of spermatogenesis against to any pathogen from the interstitial area. With the BTB integrity there is a qualified selection for the mature sperm until the lumen migration which is sperm release progress. Spermiogenesis help for the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of Fibrolytic Effect of Bauhinia purpurea L.
Clinical Cancer Drugs Computer-Aided Drug Design of Anti-inflammatory Agents Targeting Microsomal Prostaglandin E<sub>2</sub> Synthase-1 (mPGES-1)
Current Medicinal Chemistry The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke
Current Neuropharmacology Recent Advances in the Field of 16-Membered Macrolide Antibiotics
Mini-Reviews in Medicinal Chemistry Pandemic Influenza: Preventing the Emergence of Novel Strains and Countermeasures to Ameliorate its Effects
Infectious Disorders - Drug Targets Management of COVID-19 Pandemic by Immunity-modulating Ayurvedic Interventions: A Bright Panacea
Current Traditional Medicine Synthesis and Urease Inhibitory Properties of Some New N4-Substituted 5-Nitroisatin-3-thiosemicarbazones
Letters in Drug Design & Discovery Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
Current Cancer Drug Targets Ultrastructural Blood Cell Changes in Patients with COVID-19
Coronaviruses Design and Synthesis of Indole Pyrimidine Scaffolds as Potential KSP Inhibitors and Anticancer Agents
Current Enzyme Inhibition Chromenes - A Novel Class of Heterocyclic Compounds: Recent Advancements and Future Directions
Mini-Reviews in Medicinal Chemistry Interaction Models of a Series of Oxadiazole-Substituted α-Isopropoxy Phenylpropanoic Acids Against PPARα and PPARγ: Molecular Modeling and Comparative Molecular Similarity Indices Analysis Studies
Protein & Peptide Letters A Perspective on Therapeutic Applications and Strategies to Mitigate Toxicity of Metallic Nanoparticles
Current Pharmaceutical Design Docking Study of Novel Pyrrolidine Derivatives as Potential Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors
Letters in Drug Design & Discovery Is Adrenaline Always the First Choice Therapy of Anaphylaxis? An Allergist-cardiologist Interdisciplinary Point of View
Current Pharmaceutical Design Recent Developments in Patents Targeting Toll-Like Receptor Genes
Recent Patents on DNA & Gene Sequences COVID-19: An Opinion of Prevention and Dietary Based Management Hypothesis
Coronaviruses Adjuvant Therapies of COVID-19 - A Literature Review
Coronaviruses Molecular Determination of Tumor Necrosis Factor-alpha, Interleukin-8, Interleukin-10, and C-X-C Chemokine Receptor-2 Genetic Variations and their Association with Disease Susceptibility and Mortality in COVID-19 Patients
Current Genomics Fullerenes in Medicinal Chemistry and their Biological Applications
Mini-Reviews in Medicinal Chemistry